KalVista Pharmaceuticals Inc【KALV】株式ニュース | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
KalVista Pharmaceuticals Inc (KALV)
KalVista Pharmaceuticals Inc (KALV) ニュース

KalVista Pharmaceuticals Inc (KALV)

9.75

0.53

(5.75%)

終了 2月5日 6:00AM

9.75

-0.01

(-0.10%)

取引時間後: 6:58AM

個人投資家向けのプロ仕様のツール。

プレミアム

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Laurence Reid, Ph.D., has been appointed to the Company’s Board of Directors...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the Company will participate in a fireside chat at each of the following...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted twelve...

Form 8-K - Current report

KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) (“KalVista”) today announced the pricing of an underwritten offering of 5,500,000 shares of its...

1
2
次へ

Monksdream

Monksdream 7月前

KALV 10Q expected July 5

Monksdream

Monksdream 10月前

Monksdream

Monksdream 12月前

KALV new 52=week high

clydesur

clydesur 12月前

INSIDER PURCHASE / SYNDICATE

KALV - 10% OWNER Venrock Healthcare P 86,048 $14.618

Monksdream

Monksdream 1年前

KALV new 52 week high

Monksdream

Monksdream 1年前

KALV new 52 week high

Femto99

Femto99 4年前

I would not even buy the shares at $20.

Femto99

Femto99 4年前

Stock_Barber

Stock_Barber 4年前

Boom!

Killed it with puts today!

ClayTrader

ClayTrader 4年前

* * $KALV Video Chart 02-09-2021 * *

Link to Video - click here to watch the technical chart video

Stock_Barber

Stock_Barber 4年前

This company is a disaster...

make it happen

make it happen 4年前

The company is delinquent.

make it happen

make it happen 4年前

? lol

Profitability
Profit Margin 0.00%
Gross Profit (ttm) $-27.5M
EBITDA $-48.38M
Net Income Avi to Common (ttm) $-37.12M
Diluted EPS (ttm) -2.08

Book Value Per Share (mrq) $3.63

Going to keep diluting more and more

make it happen

make it happen 4年前

They are hemorrhaging money. Have pretty much zero revenue. They still have hundreds of millions to spend of your money until phase 3 and beyond.

Operating Margin (ttm) -905.50%

Management Effectiveness

Return on Assets (ttm) -32.60%
Return on Equity (ttm) -45.61%

Revenue $5.4M
Revenue Per Share $0.30

TFMG

$KALV Kalvista Pharma Trend Break

Major Downtrend broken
Broken above 200ma
Volume increased
MACD reversed
RSi in bullish uptrend

whytestocks

whytestocks 6年前

News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr...

Find out more https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-appoints-daniel-b-soland-to-board-of-directors-8035190.html

whytestocks

whytestocks 6年前

News: $KALV KalVista Pharmaceuticals to Present at Needham Healthcare Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Healthcare Conference on Wednesday, April 10, 2019, a...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-to-present-at-needham-healthcare-conference-7939130.html

stocktrademan

stocktrademan 6年前

KALV buy 28.87

normal chart

log chart

whytestocks

whytestocks 6年前

News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 – – Oral Plasma Kallikrein Inhibitor Candidate KVD824 Dosi...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-reports-fiscal-third-quarter-results-7846828.html

countryrapper2000

countryrapper2000 7年前

Where is everyone?

TheFinalCD

TheFinalCD 7年前

$17.85 !!

KALV

Lone Wolf

Lone Wolf 7年前

Sniffer rocket ship today!! Wheeee.

KALV

TheFinalCD

TheFinalCD 7年前

$15.50 now ~ keep rollin

$KALV

kondziu

kondziu 8年前

http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623

Warchest

Warchest 8年前

$8.25 now ~ keep rollin

ming1234

ming1234 8年前

any positive news and volume will move this north

Warchest

Warchest 8年前

LIVE action starting !!!

Warchest

Warchest 8年前

watching close ~

Toxic Avenger

Toxic Avenger 8年前

The way this is dropping, there has to be a lawsuit over the sale of cash at 60% off.
Where are those ambulance chasing securities lawyers?

MSparks6

MSparks6 8年前

So when will CBYL holders be issued KALV common stock?

Toxic Avenger

Toxic Avenger 8年前

CBYL is now KALV with a 1:14 reverse stock split.

Be very careful for the next few days as until all or most of the CBYL shares are converted to KALV, the only sellers will be private Kal Vista investors, those who bought after the symbol change and professionals. The price is likely to be high until existing CBYL retail holders can sell their shares. In addition, the existing CBYL shares will only represent 20% of the O/S. 80% will be held by the private investors in KVAL.

Iam_in

Iam_in

New Ticker symbol now: KALV

Iam_in

Correction : $5.49 PM

Iam_in

WOW - look at this $0,89---> $4,60

New Ticker name now : KALV

look at NASDAQ - PM

Toxic Avenger

Toxic Avenger 8年前

Apparently the merger deal was approved by a huge margin.

Still don't get it.

ClayTrader

ClayTrader 8年前

* * $CBYL Video Chart 11-21-16 * *

Link to Video - click here to watch the technical chart video

beginneer

beginneer 8年前

Attempting to break 0.72. GL to holders

beginneer

beginneer 8年前

We'll see how this goes. Hopefully back to over a dollar.

Toxic Avenger

Toxic Avenger 8年前

CBYL continuing its upward momentum pre-market.

ClayTrader

ClayTrader 8年前

* * $CBYL Video Chart 11-18-16 * *

Link to Video - click here to watch the technical chart video

beginneer

beginneer 8年前

Oh okay. Im still up for it even if it is a merger. Good thing volume picked up today.

Toxic Avenger

Toxic Avenger 8年前

New buyer? They're not being bought, they're merging with another company and selling their cash at a steep discount.

Maybe the large shareholders decided it's better to take a smaller loss now by liquidating, than wait for a larger loss later and they're voting against the deal.

I can only hope!

beginneer

beginneer 8年前

Somethings fishy going on here. Why the sudden spike in volume? New buyer in sight?

Toxic Avenger

Toxic Avenger 8年前

Fun while it lasted.

Toxic Avenger

Toxic Avenger 8年前

Big bounce today. Anyone know why?

Toxic Avenger

Toxic Avenger 8年前

$700k / month for a company that has only a few execs and no business left???

No wonder they want to merge. If they liquidate, the execs all lose their gravy train.

Maybe that can be part of the class action suit.

Toxic Avenger

Toxic Avenger 8年前

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Toxic Avenger

Toxic Avenger 8年前

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Toxic Avenger

Toxic Avenger 8年前

Sadly, I don't think so.

KalVista Pharmaceuticals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約